• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒(SARS-CoV-2)的轻症长期携带者表现出先天性抵抗力受损,但高亲和力抗刺突抗体增加。

Oligosymptomatic long-term carriers of SARS-CoV-2 display impaired innate resistance but increased high-affinity anti-spike antibodies.

作者信息

Montes-Cobos Elena, Bastos Victoria C, Monteiro Clarice, de Freitas João C R, Fernandes Heiny D P, Constancio Clarice S, Rodrigues Danielle A S, Gama Andreza M D S, Vidal Vinicius M, Alves Leticia S, Zalcberg-Renault Laura, de Lira Guilherme S, Ota Victor A, Caloba Carolina, Conde Luciana, Leitão Isabela C, Tanuri Amilcar, Ferreira Orlando D C, Pereira Renata M, Vale André M, Castiñeiras Terezinha M, Kaiserlian Dominique, Echevarria-Lima Juliana, Bozza Marcelo T

机构信息

Laboratório de Inflamação e Imunidade, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Departamento de Doenças Infecciosas e Parasitárias, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

iScience. 2023 Jun 28;26(7):107219. doi: 10.1016/j.isci.2023.107219. eCollection 2023 Jul 21.

DOI:10.1016/j.isci.2023.107219
PMID:37529320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10300054/
Abstract

The vast spectrum of clinical features of COVID-19 keeps challenging scientists and clinicians. Low resistance to infection might result in long-term viral persistence, but the underlying mechanisms remain unclear. Here, we studied the immune response of immunocompetent COVID-19 patients with prolonged SARS-CoV-2 infection by immunophenotyping, cytokine and serological analysis. Despite viral loads and symptoms comparable to regular mildly symptomatic patients, long-term carriers displayed weaker systemic IFN-I responses and fewer circulating pDCs and NK cells at disease onset. Type 1 cytokines remained low, while type-3 cytokines were in turn enhanced. Of interest, we observed no defects in antigen-specific cytotoxic T cell responses, and circulating antibodies displayed higher affinity against different variants of SARS-CoV-2 Spike protein in these patients. The identification of distinct immune responses in long-term carriers adds up to our understanding of essential host protective mechanisms to ensure tissue damage control despite prolonged viral infection.

摘要

新冠病毒病(COVID-19)广泛的临床特征持续挑战着科学家和临床医生。对感染的低抵抗力可能导致病毒长期持续存在,但其潜在机制仍不清楚。在此,我们通过免疫表型分析、细胞因子和血清学分析,研究了免疫功能正常但感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)时间延长的COVID-19患者的免疫反应。尽管病毒载量和症状与普通轻症患者相当,但长期携带者在疾病发作时全身I型干扰素(IFN-I)反应较弱,循环浆细胞样树突状细胞(pDC)和自然杀伤(NK)细胞较少。1型细胞因子水平仍然较低,而3型细胞因子则相应升高。有趣的是,我们观察到这些患者的抗原特异性细胞毒性T细胞反应没有缺陷,并且循环抗体对SARS-CoV-2刺突蛋白的不同变体显示出更高的亲和力。长期携带者中独特免疫反应的识别,进一步加深了我们对基本宿主保护机制的理解,以确保尽管病毒感染持续时间延长,但仍能控制组织损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/f62db0c7392c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/1d49a6b100a8/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/133c185f692c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/7173ad92b73d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/ab9288cdeb42/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/ed96b655ccdc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/f62db0c7392c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/1d49a6b100a8/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/133c185f692c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/7173ad92b73d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/ab9288cdeb42/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/ed96b655ccdc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/10392077/f62db0c7392c/gr5.jpg

相似文献

1
Oligosymptomatic long-term carriers of SARS-CoV-2 display impaired innate resistance but increased high-affinity anti-spike antibodies.新冠病毒(SARS-CoV-2)的轻症长期携带者表现出先天性抵抗力受损,但高亲和力抗刺突抗体增加。
iScience. 2023 Jun 28;26(7):107219. doi: 10.1016/j.isci.2023.107219. eCollection 2023 Jul 21.
2
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.COVID-19 康复者感染后 1 年的 SARS-CoV-2 特异性抗体和 T 细胞反应:一项纵向队列研究。
Lancet Microbe. 2022 May;3(5):e348-e356. doi: 10.1016/S2666-5247(22)00036-2. Epub 2022 Mar 23.
3
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
4
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.在无症状至轻症 COVID-19 感染至少 8 个月后,仍能产生强大的体液和细胞免疫反应,并降低再次感染的风险。
J Intern Med. 2022 Jan;291(1):72-80. doi: 10.1111/joim.13387. Epub 2021 Sep 27.
5
Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.纵向免疫分析揭示了介导 COVID-19 恢复期个体长期体液免疫的优势表位。
J Allergy Clin Immunol. 2022 Apr;149(4):1225-1241. doi: 10.1016/j.jaci.2022.01.005. Epub 2022 Jan 21.
6
Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.COVID-19 患者再次检测到病毒 RNA 阳性时存在低固有免疫和滞后适应性免疫反应。
Front Immunol. 2021 Jul 1;12:664619. doi: 10.3389/fimmu.2021.664619. eCollection 2021.
7
Diversity of immune responses in children highly exposed to SARS-CoV-2.儿童对 SARS-CoV-2 高度暴露后的免疫反应多样性。
Front Immunol. 2023 Mar 3;14:1105237. doi: 10.3389/fimmu.2023.1105237. eCollection 2023.
8
Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation.双重机制:表观遗传抑制剂 apabetalone 降低 SARS-CoV-2 Delta 和 Omicron 变异株刺突结合并减弱 SARS-CoV-2 RNA 诱导的炎症。
Int Immunopharmacol. 2023 Apr;117:109929. doi: 10.1016/j.intimp.2023.109929. Epub 2023 Feb 23.
9
Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination.尽管对 SARS-CoV-2 mRNA 疫苗接种的循环 T 细胞反应迅速收缩,但仍存在持久记忆。
Front Immunol. 2023 Feb 13;14:1100594. doi: 10.3389/fimmu.2023.1100594. eCollection 2023.
10
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.对 SARS-CoV-2 特异性 T 细胞细胞因子产生反应进行为期 1 年的纵向评估显示,多细胞因子增殖反应具有持久性,且与疾病严重程度相关的免疫应答更强。
J Virol. 2022 Jul 13;96(13):e0050922. doi: 10.1128/jvi.00509-22. Epub 2022 Jun 14.

引用本文的文献

1
Pulmonary and Immune Dysfunction in Pediatric Long COVID: A Case Study Evaluating the Utility of ChatGPT-4 for Analyzing Scientific Articles.儿童长期新冠后的肺部和免疫功能障碍:一项评估ChatGPT-4分析科学文章效用的案例研究
J Clin Med. 2025 Aug 25;14(17):6011. doi: 10.3390/jcm14176011.

本文引用的文献

1
Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection.瑞德西韦在延长感染患者体内诱导出现 SARS-CoV2 变异株。
Cell Rep Med. 2022 Sep 20;3(9):100735. doi: 10.1016/j.xcrm.2022.100735. Epub 2022 Aug 16.
2
From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics.从重组关键抗原到准确、可负担的血清学检测:从新冠疫情中汲取的经验教训,以应对未来大流行。
Biochem Eng J. 2022 Aug;186:108537. doi: 10.1016/j.bej.2022.108537. Epub 2022 Jul 16.
3
Prolonged SARS-CoV-2 Positivity in Immunocompetent Patients: Virus Isolation, Genomic Integrity, and Transmission Risk.
免疫功能正常患者中 SARS-CoV-2 持续阳性:病毒分离、基因组完整性和传播风险。
Microbiol Spectr. 2021 Dec 22;9(3):e0085521. doi: 10.1128/Spectrum.00855-21. Epub 2021 Nov 17.
4
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.无症状和重症 COVID-19 感染中的浆细胞样树突状细胞表型和 I 型干扰素反应的差异。
PLoS Pathog. 2021 Sep 2;17(9):e1009878. doi: 10.1371/journal.ppat.1009878. eCollection 2021 Sep.
5
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.急性 SARS-CoV-2 感染期间的不同系统和黏膜免疫应答。
Nat Immunol. 2021 Nov;22(11):1428-1439. doi: 10.1038/s41590-021-01028-7. Epub 2021 Sep 1.
6
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.早期针对 SARS-CoV-2 的鼻腔 I 型 IFN 免疫被针对 I 型 IFN 的自身抗体患者削弱。
J Exp Med. 2021 Oct 4;218(10). doi: 10.1084/jem.20211211. Epub 2021 Aug 6.
7
Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?新型冠状病毒肺炎中白细胞介素-10水平升高:促炎反应增强还是抗炎作用受损?
Front Immunol. 2021 Jun 21;12:677008. doi: 10.3389/fimmu.2021.677008. eCollection 2021.
8
SARS-CoV-2 Variants and Vaccines.SARS-CoV-2 变异株与疫苗。
N Engl J Med. 2021 Jul 8;385(2):179-186. doi: 10.1056/NEJMsr2105280. Epub 2021 Jun 23.
9
Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.动态先天免疫反应决定了对 SARS-CoV-2 感染的易感性和早期复制动力学。
J Exp Med. 2021 Aug 2;218(8). doi: 10.1084/jem.20210583. Epub 2021 Jun 15.
10
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.纵向分析显示,迟发性旁观者 CD8+T 细胞激活和早期免疫病理学将重症 COVID-19 与轻症疾病区分开来。
Immunity. 2021 Jun 8;54(6):1257-1275.e8. doi: 10.1016/j.immuni.2021.05.010. Epub 2021 May 16.